| scholarly article | Q13442814 |
| P50 | author | Adria Giacca | Q80162695 |
| Paul W. Frankland | Q88416174 | ||
| P2093 | author name string | Peixiang Wang | |
| Julie Turnbull | |||
| Xiaochu Zhao | |||
| Taline Naranian | |||
| Sandra Pereira | |||
| Anne L. Wheeler | |||
| Mark Piliguian | |||
| Arman Draginov | |||
| Nela Pencea | |||
| Nyrie Israelian | |||
| Erica Tiberia | |||
| Cameron A. Ackerley | |||
| Berge A. Minassian | |||
| Alexander Ivovic | |||
| Wen Qin Yu | |||
| P2860 | cites work | Acute dipeptidyl peptidase-4 inhibition rapidly enhances insulin-mediated suppression of endogenous glucose production in mice. | Q46359322 |
| Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding | Q46510044 | ||
| Glucose metabolism in mice lacking muscle glycogen synthase | Q46818629 | ||
| Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. | Q46938722 | ||
| Liver and peripheral tissue glycogen metabolism in obese mice: effect of a mixed meal. | Q51598444 | ||
| Deficiency of Sbds in the mouse pancreas leads to features of Shwachman-Diamond syndrome, with loss of zymogen granules. | Q52624374 | ||
| Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. | Q54299084 | ||
| Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. | Q54332121 | ||
| Glycogen storage capacity and de novo lipogenesis during massive carbohydrate overfeeding in man. | Q55060542 | ||
| Metabolic impact of overexpression of liver glycogen synthase with serine-to-alanine substitutions in rat primary hepatocytes | Q64376964 | ||
| Evidence for a role of glucose-induced translocation of glucokinase in the control of hepatic glycogen synthesis | Q64382655 | ||
| Evidence for suppression of hepatic glucose-6-phosphatase with carbohydrate feeding | Q70184484 | ||
| Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction | Q74191142 | ||
| A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance | Q77652485 | ||
| Phosphatidylinositol 3-kinase translocates onto liver endoplasmic reticulum and may account for the inhibition of glucose-6-phosphatase during refeeding | Q77912057 | ||
| A gel filtration assay to determine glycogen synthase activity | Q81706753 | ||
| Glycogen and its Metabolism | Q22305786 | ||
| Molecular physiology of mammalian glucokinase | Q24653018 | ||
| Early-onset Lafora body disease | Q28119103 | ||
| Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV) | Q28285077 | ||
| Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice | Q28511659 | ||
| PTG, a protein phosphatase 1-binding protein with a role in glycogen metabolism | Q28591679 | ||
| Identification of a novel protein interacting with laforin, the EPM2a progressive myoclonus epilepsy gene product | Q30940680 | ||
| The Croonian Lecture 1998. Identification of a protein kinase cascade of major importance in insulin signal transduction | Q33599031 | ||
| Impaired glucose tolerance and predisposition to the fasted state in liver glycogen synthase knock-out mice | Q33800037 | ||
| Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism | Q33830715 | ||
| Identification of binding sites on protein targeting to glycogen for enzymes of glycogen metabolism. | Q33913304 | ||
| Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin | Q34055790 | ||
| Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation | Q34089899 | ||
| Mutations in NHLRC1 cause progressive myoclonus epilepsy | Q34228381 | ||
| Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus | Q34236518 | ||
| Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake | Q34243161 | ||
| Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy | Q34754070 | ||
| Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease | Q36038840 | ||
| Link between obesity and type 2 diabetes | Q36324084 | ||
| Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms | Q37359438 | ||
| Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans | Q37379144 | ||
| Regulation of muscle glycogen synthase phosphorylation and kinetic properties by insulin, exercise, adrenaline and role in insulin resistance. | Q37408157 | ||
| Allosteric regulation of glycogen synthase controls glycogen synthesis in muscle | Q39638100 | ||
| Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle | Q40721809 | ||
| Zonation of parenchymal and nonparenchymal metabolism in liver | Q41138372 | ||
| Role of glucose effectiveness in the determination of glucose tolerance | Q41170043 | ||
| Abnormal metabolism of glycogen phosphate as a cause for Lafora disease | Q41502630 | ||
| Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes | Q41743578 | ||
| Glycogen hyperphosphorylation underlies lafora body formation | Q42815700 | ||
| Dysregulation of glycogen synthase COOH- and NH2-terminal phosphorylation by insulin in obesity and type 2 diabetes mellitus | Q43259516 | ||
| Progressive defect of insulin action on glycogen synthase in obesity and diabetes | Q43973161 | ||
| Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease | Q44055638 | ||
| Exercise capacity of mice genetically lacking muscle glycogen synthase: in mice, muscle glycogen is not essential for exercise | Q45265130 | ||
| Hyperinsulinemic-euglycemic clamp to assess insulin sensitivity in vivo. | Q45979025 | ||
| P433 | issue | 48 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | insulin resistance | Q1053470 |
| preproinsulin | Q7240673 | ||
| Glycogen synthase 1, muscle | Q21496445 | ||
| EPM2A (laforin) interacting protein 1 | Q21981084 | ||
| P304 | page(s) | 34627–34637 | |
| P577 | publication date | 2013-11-29 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Deficiency of a glycogen synthase-associated protein, Epm2aip1, causes decreased glycogen synthesis and hepatic insulin resistance | |
| P478 | volume | 288 |
Search more.